Zyla Health, a dynamic health-tech startup based in Gurgaon, India, has successfully secured $4 million in its Series A funding round. This significant investment, led by Exfinity Venture Partners, marks a crucial milestone in Zyla’s mission to transform healthcare delivery in India. The funding round also saw participation from other key investors, including the Sony Innovation Fund, Venture Catalysts, and Aureolis, led by Paula Mariwala.
Prior to this, Zyla Health had raised $1 million in a pre-Series A round in July of the previous year from a group of angel investors. The company’s institutional backers include Kae Capital, Secocha Ventures, Canara Bank Ventures, and Seeders.
Zyla Health differentiates itself in the health-tech landscape with a robust platform dedicated to providing personalized care for individuals with chronic health conditions. The platform, supported by an in-house care team, integrates seamlessly across the healthcare ecosystem through application programming interfaces (APIs). This integration encompasses client data lakes, diagnostic vendors, and smart devices, ensuring scalability and effective service delivery.
Khushboo Aggarwal, the Founder and CEO of Zyla Health, expressed her excitement about the company’s growth trajectory. She highlighted the company’s achievement of 300% year-on-year growth and 100% retention of its key B2B accounts over the last year. With a strong leadership team and fresh capital, Zyla Health aims to revolutionize healthcare delivery in India.
The Series A funding is set to catalyze Zyla Health’s ambitious growth plans, focusing on three core verticals: insurance, corporates, and big pharma. The funds will also be channeled towards enhancing product integrations across the healthcare ecosystem to improve scalability.
Over the past year, Zyla Health has successfully onboarded new clients, including Max Life Insurance, HDFC Ergo, Pfizer, Zydus, IBM, DHL, Godrej, GEP, and others. The platform’s value proposition lies in its ability to improve health conditions for high-risk individuals, thereby reducing insurance claims and premiums for corporate clients. Additionally, Zyla Health is committed to enhancing medication outcomes and adherence for pharmaceutical drug users.
The successful funding round not only validates Zyla Health’s innovative approach but also positions the company to play a transformative role in the Indian healthcare landscape. The support from investors like Exfinity Venture Partners and others signifies confidence in Zyla’s capability to drive meaningful innovation in healthcare delivery. The emphasis on scalability through API integrations with various data and service providers positions Zyla as a technology-driven enabler of comprehensive healthcare solutions, aligning with the evolving landscape of healthcare technology